文献速递肾小球疾病

更新儿童IgA肾病国际预测工具

Updating the International IgA Nephropathy Prediction Tool for use in children.
PubMed 文献 · Kidney Int · 2020-11-18

儿童IgA肾病缺乏进展预测方法,限制了个体化治疗决策。研究基于1060例多民族儿童队列更新国际IgA肾病预测工具,采用30% eGFR下降或ESKD为结局,模型拟合与校准良好,C统计量为0.74/0.68。

要点

  • 儿童IgA肾病预测工具以30% eGFR下降或ESKD为终点,校准良好。
  • 儿童eGFR轨迹非线性,18岁前上升后线性下降,与成人不同。
  • 预测风险越高,eGFR上升越小且后续下降越快,提示儿童30%下降等同于成人50%下降。

核心结论

  • 更新的儿童IgA肾病预测工具可准确预测儿童30% eGFR下降或ESKD风险。

研究设计与样本

  • 多民族国际队列,纳入1060例儿童IgA肾病患者并随访至成年。

主要发现

  • 更新版儿童工具模型拟合优于成人工具,AIC更低、R2D更高,C统计量相似。
  • 以50% eGFR下降或ESKD为结局时校准极差,预测风险与观察风险一致性很差。
  • 改用30% eGFR下降或ESKD为结局后,R2D为30.3%/22.2%,C统计量为0.74/0.68,校准良好。
  • 儿童eGFR轨迹高度非线性,18岁前上升,之后线性下降类似成人。
  • 预测风险越高,eGFR上升越小且后续下降越快。

关键数值与推荐

  • 儿童工具预测结局为30% eGFR下降或ESKD,R2D为30.3%/22.2%,C统计量为0.74/0.68。

临床怎么用

  • 可用于儿童IgA肾病风险分层,辅助个体化治疗决策。
  • 儿童采用30% eGFR下降或ESKD作为预测终点,与成人50%下降终点对应。

局限性

  • 以50% eGFR下降或ESKD为结局时校准极差,可能与儿童疾病轨迹有关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although IgA nephropathy (IgAN) is a common cause of glomerulonephritis in children, the absence of a method to predict disease progression limits personalized risk-based treatment decisions. The adult International IgAN Prediction Tool comprises two validated Cox survival models that predict a 50% decline in estimated glomerular filtration rate (eGFR) or end stage kidney disease (ESKD) using clinical risk factors and Oxford MEST histology scores. Here, we updated the Prediction Tool for use in children using a multiethnic international cohort of 1,060 children with IgAN followed into adulthood. The updated pediatric Prediction Tool had better model fit than the original adult tool with lower Akaike Information Criterion, higher R2D and similar C-statistics. However, calibration showed very poor agreement between predicted and observed risks likely due to the observed disease trajectory in children. Therefore, the Tool was updated using a secondary outcome of a 30% reduction in eGFR or ESKD, resulting in better R2D (30.3%/22.2%) and similar C-statistics (0.74/0.68) compared to the adult tool but with good calibration. The trajectory of eGFR over time in children differed from adults being highly non-linear with an increase until 18 years old followed by a linear decline similar to that of adults. A higher predicted risk was associated with a smaller increase in eGFR followed by a more rapid decline, suggesting that children at risk of a 30% decrease in eGFR will eventually experience a larger 50% decrease in eGFR when followed into adulthood. As such, these two outcomes are analogous between pediatric and adult Prediction Tools. Thus, our pediatric Prediction Tool can accurately predict the risk of a 30% decline in eGFR or ESKD in children with IgAN.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Barbour SJ, Coppo R, Er L, et al. Updating the International IgA Nephropathy Prediction Tool for use in children. Kidney Int. 2020. PMID: 33220356. doi:10.1016/j.kint.2020.10.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。